The World Health Organisation (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for the treatment of type 2 diabetes and obesity in some countries.
Trending
- N-HYPPADEC seeks tougher safety measures to curb boat mishaps
- FairMoney bank stresses compliance, consumer protection
- RHCC takes child-killer disease fight to Kebbi communities
- NGO expands cancer awareness in Adamawa
- NBMA warns against spreading false Ebola information
- Tanzania’s vitamin A-rich bananas promise to prevent 33% of child blindness, protect pregnant mothers
- Doctor migration threatens Nigeria’s healthcare, expert warns
- Delta empowers 17,590 farmers through D-CARES
